Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Plos One|February 18, 2014
How river rocks round: resolving the shape-size paradoxGabor Domokos, Douglas J Jerolmack, Andras Á Sipos, et al.
Blood Transfusion = Trasfusione Del Sangue|August 9, 2012
Geographical variations in current clinical practice on transfusions and iron chelation therapy across various transfusion-dependent anaemiasVip Viprakasit, Norbert Gattermann, Jong Wook Lee, et al.
European Journal of Haematology|June 9, 2011
Response of iron overload to deferasirox in rare transfusion-dependent anaemias: equivalent effects on serum ferritin and labile plasma iron for haemolytic or production anaemiasJohn B Porter, Kai-Hsin Lin, Photis Beris, et al.
Blood|June 23, 2010
Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trialJong Wook Lee, Sung-Soo Yoon, Zhi Xiang Shen, et al.
Leukemia Research|May 11, 2010
Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC studyNorbert Gattermann, Carlo Finelli, Matteo Della Porta, et al.
International Journal of Hematology|March 5, 2011
Clinical efficacy and safety evaluation of tailoring iron chelation practice in thalassaemia patients from Asia-Pacific: a subanalysis of the EPIC study of deferasiroxVip Viprakasit, Hishamshah Ibrahim, Shau-Yin Ha, et al.
Haematologica|January 25, 2012
Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with β-thalassemia majorDudley J Pennell, John B Porter, Maria Domenica Cappellini, et al.
Haematologica|November 13, 2010
Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overloadDudley J Pennell, John B Porter, Maria Domenica Cappellini, et al.
Blood|December 10, 2009
Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemiaDudley J Pennell, John B Porter, Maria Domenica Cappellini, et al.
Haematologica|December 3, 2009
Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemiasMaria Domenica Cappellini, John Porter, Amal El-Beshlawy, et al.
Pageof 1